Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 9Gastrointestinal 6Genitourinary 4CNS 3Thoracic 2Lymphoid 2Gynecologic 2Tumor-Agnostic 1Sarcoma 1Other hematologic neoplasm 1Head & Neck 1

Conditions

Uterine Cervical Neoplasms 2Rectal Neoplasms 1Oropharyngeal Neoplasms 1Hypoxia 1Anus Neoplasms 1

Interventions

Paclitaxel 74pembrolizumab 59Carboplatin 55Bevacizumab 54Specimen Handling 47Magnetic Resonance Spectroscopy 38Cisplatin 32olaparib 28Gemcitabine 25liposomal doxorubicin 24Biopsy 20Taxes 18Topotecan 17Nivolumab 17Doxorubicin 15Cyclophosphamide 15Immunoglobulin G 14Disulfides 14niraparib 12fludarabine 12lenvatinib 11Surveys and Questionnaires 11Letrozole 11atezolizumab 10Drug Therapy 10durvalumab 9Fulvestrant 9Docetaxel 9Brachytherapy 9mirvetuximab soravtansine 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Magnetic Resonance Imaging × Gynecologic × 90 days × Clear all
NCT04432597 2026-05-18

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
39 enrolled
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

NCT05029258 2026-05-12

Bio-CHECC

University of Manchester

Active not recruiting
30 enrolled
Gynecologic

Hypoxia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡